How has Tango Therapeutics's interest income (expense), operating changed year-over-year?

Tango Therapeutics's interest income (expense), operating increased by 34.9% year-over-year, from $1.61M to $2.18M.

What is the long-term trend for Tango Therapeutics's interest income (expense), operating?

Over 4 years (2021 to 2025), Tango Therapeutics's interest income (expense), operating has grown at a 83.6% compound annual growth rate (CAGR), from $495K to $5.63M.

Tango Therapeutics TNGX Interest Income (Expense), Operating

Interest Income (Expense), Operating at other companies

PopularBPOP

$670.18M+10.7%

Morgan StanleyMS

$2.7B+14.9%

Robinhood Markets, Inc.HOOD

$359M+23.8%

Essential UtilitiesWTRG

$425.75K-48.7%

DiodesDIOD

$3.42M-19.7%

PopularBPOP

$670.18M+10.7%

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNet.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's interest income (expense), operating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's interest income (expense), operating?: Tango Therapeutics (TNGX) reported interest income (expense), operating of $2.18M in Q1 2026.
How has Tango Therapeutics's interest income (expense), operating changed year-over-year?: Tango Therapeutics's interest income (expense), operating increased by 34.9% year-over-year, from $1.61M to $2.18M.
What is the long-term trend for Tango Therapeutics's interest income (expense), operating?: Over 4 years (2021 to 2025), Tango Therapeutics's interest income (expense), operating has grown at a 83.6% compound annual growth rate (CAGR), from $495K to $5.63M.